CC
MRNA icon

Cadinha & Co’s Moderna MRNA Stock Holding History

Cadinha & Co’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,072
Closed -$205K – 105
2024
Q3 		$205K Sell
3,072
-79,121
-96% -$7.26M 0.04% 98
2024
Q2 		$9.76M Buy
82,193
+532
+0.7% +$67.3K 1.81% 22
2024
Q1 		$8.7M Sell
81,661
-177
-0.2% -$17.8K 1.5% 27
2023
Q4 		$8.14M Buy
81,838
+42,685
+109% +$3.59M 1.3% 33
2023
Q3 		$4.04M Buy
39,153
+690
+2% +$77K 0.89% 27
2023
Q2 		$4.67M Buy
38,463
+768
+2% +$102K 0.85% 29
2023
Q1 		$5.79M Buy
+37,695
New +$6.22M 1.59% 22
2021
Q4 		– Sell
-1,350
Closed -$520K – 123
2021
Q3 		$520K Buy
+1,350
New +$498K 0.07% 80

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Cadinha & Co's MRNA Position: Q4 2024 in Review

Cadinha & Co sold out of Moderna (MRNA) in Q4 2024, closing a stake of 3,072 shares — an estimated $205K sold.

Cadinha & Co first reported a position in MRNA in Q3 2021 and held it in 8 quarters. The position peaked at $9.76M in Q2 2024. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Cadinha & Co reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Cadinha & Co sold 3,072 Moderna shares in Q4 2024, an estimated $205K.
  • Cadinha & Co first reported a position in Moderna in Q3 2021 and held it in 8 quarters.
  • Cadinha & Co's Moderna position peaked at $9.76M in Q2 2024.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Cadinha & Co's 13F filing for Q4 2024, filed 16 Jan 2025.